Purchase 4-CDC
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy 4-CDC for sale
4-CDC is a new stimulant similar to 4cec, 4cmc, and 3cmc, but the effect can last longer than others, so it's very popular now. This product was made after the China law, which banned 116 chemicals and is legal worldwide.
4-CDC is a powerful new stimulant very similar to 4CEC, 4CDEC, 3CDEC and so on. It has become very popular lately because of the positive effects it has. This is because the law in China banned 116 chemicals except for this substance. Therefore, there are no laws against its possession or distribution, making it legal worldwide.
4-CDC is a novel stimulant that has become very popular with its duration of action and powerful psychedelic effects. This product was synthesized after China banned 116 chemical substances, which include 4-CEC (4-chloroethcathinone), another stimulant drug.
4-CDC is a brightly colored, crystalline powder known for its long-lasting effects. It's a perfect substitute for other chemical compounds such as 3CMC and 4CEC.
4-CDC is a new stimulant similar to 4cec, 4cmc, and 3cmc, but the effect can last longer than others, so it's very popular now. It was made after the China law, which banned 116 chemicals and is therefore legal worldwide.
4CDC is a new stimulant similar to 4CEc. It is also known as 4cmc and 3cmc, as well as 4CDEC. The duration of the effect is longer than other stimulants on the market today. It's a pure white crystal with a bitter smell, which can dissolve in water or ethanol
4CDC is an exciting new stimulant, similar to 4-CEEC, 4-CMC, and 3-CMC. At just .11 milligrams per dose, this active ingredient is a good choice for those who wish to experience the effects of a stimulant without extreme nausea that many experiences with other comparable substances. (150mcg)
4CDC (4-chloro-2,5-dimethoxy-substituted phenethylamine) is a psychedelic phenethylamine of the 2C family. This compound is extensively bioactive in its own right, but it is weak compared to other psychedelics.
4-CDC, also known as 4-chloro-2,5-dimethoxyphenethylamine, is a slightly more potent analog of 2C-D with comparable effects as the latter. Alexander Shulgin invented it in 1997. It produces psychedelic and entactogenic effects similar to its parent compound 2C-D.
4-CDC is a psychedelic and entactogenic drug of the phenethylamine chemical class that produces an array of psychedelic and entactogenic effects when administered.
4-CDC, or 4-chloro-2,5-dimethoxyphenethylamine is a psychedelic phenethylamine of the 2C family. The raw chemical is not active in its pure form and must be transformed to become psychoactive.
4-Chloro-2,5-dimethoxyphenethylamine (also known as 2C-C, punch, and "dosage") is a semi-common chemical of the phenethylamine class that produces psychedelic effects similar to that of other lysergamides. It is a member of the so-called "magical half-dozen," which refers to Shulgin's self-rated most important phenethylamine compounds.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics